 |
| (Guest)editors | | Volume & journal title |
|
| |
| Volume 31, Supplement 2: |
| Clinical relevance of increasing glycopeptide MICs against Staphylococcus aureus. The publication of this supplement was supported by an educational grant from Novartis. |
|
| ( 16 ) |
|
| |
| Volume 31, Supplement 1: |
| Urinary Tract Infections Supplement, International Symposia on Urinary Tract Infection |
|
| ( 116 ) |
|
| |
| Volume 30, Supplement 2: |
| Augmentin Supplement, twenty five years of Augmentin (amoxicillin/clavulanate: its heritage and the continuing evolution of antibacterial therapy) |
|
| ( 34 ) |
|
| |
| Volume 30, Supplement 1: |
| Bloodstream Infections Supplement, International Society of Chemotherapy (ISC) Disease Management Series Symposium |
|
| ( 108 ) |
|
| |
| Volume 28, Supplement 2: |
| Respiratory tract infections:at-risk patients, who are they? Implications for their management with levofloxacin |
|
| ( 16 ) |
|
| |
| Volume 28, Supplement 1: |
| Proceedings of the 9th International Symposium on Urinary Tract Infection held during the 24th International Congress of Chemotherapy 4-6 June 2005 in Manila, The Philippines |
|
| ( 112 ) |
|
| |
| Volume 27, Supplement 1: |
| Managing Challenges of Fungal Infections. Abelcet Standalone Meeting, Berlin, November 2004 |
|
| ( 44 ) |
|
| |
| Volume 26, Supplement 3: |
| Single-Dose Azithromycin for the Treatment of Respiratory Tract Infections |
|
| ( 35 ) |
|
| J.J. Picazo | |
| Volume 26, Supplement 2: |
| Asia Pacific Clinical Practice Guidelines on Febrile Neutropenia - Proceedings of the concencus meeting held 29-30 November 2004 in Bangkok, Thailand |
|
| ( 28, Paperback ) |
|
| Pena, Lansang, Asuncion Silvestre | |
| Volume 26, Supplement 1: |
| 24th International Congress on Chemotherapy |
|
| ( 116, Paperback ) |
|
| |
| Volume 24, Supplement 2: |
| Abstracts presented at the The 6th European congress of chemotherapy and infection and the 24th Interdisciplinary meeting on anti-infection chemotherapy. |
|
| ( 271, Paperback ) |
|
| K.G. Naber, S. Kamidono, J.W. Warren | |
| Volume 24, Supplement 1: |
| Proceedings of the 8th International Symposium on Clinical Evaluation of Drug Efficacy in Urinary Tract Infection |
|
| ( 75, Paperback ) |
|
| K.G. Naber, J.C. Pechere, E. Ludwig et al. | |
| Volume 23, Supplement 1: |
| Part II of the International Symposium Hot Topics in Urinary Tract Infection |
|
| ( 87, Paperback ) |
|
| K.G. Naber, J.C. Pechere, E. Ludwig et al. | |
| Volume 22, Supplement 2: |
| Part I of the International Symposium Hot Topics in Urinary Tract Infection |
|
| ( 73, Paperback ) |
|
| J.C. Pechere | |
| Volume 22, Supplement 1: |
| Susceptibility Breakpoints, the Patients First. Reevaluating the value of breakpoints |
|
| ( 26, Paperback ) |
|
| F. Moosdeen | |
| Volume 22, Number 3: |
| Efflux pumps and antibiotic resistance of microorganisms |
|
| ( 182, Paperback ) |
|
| |
| Volume 20, Supplement 1: |
| Guidelines for the management of Community-Acquired Pneumonia in Saudi Arabia: a model for the Middle East region |
|
| ( 12, Paperback ) |
|
| |
| Volume 19, Supplement 1: |
| 4th European Congress of Chemotherapy and Infection Abstracts |
|
| ( 121, Paperback ) |
|
| |
| Volume 18, Supplement 1: |
| Microlides |
|
| ( 99, Paperback ) |
|
| |
| Volume 17, Supplement 1: |
| Abstracts of the 22nd International Congress of Chemotherapy, |
|
| ( 190, Paperback ) |
|
| Y. Kawada, J.W. Warren, K.G. Naber | |
| Volume 17, Number 4: |
| Urinary Tract Infection |
|
| ( 107 pages ) |
|
| |
| Volume 16, Number 3: |
| International Meeting on Antimicrobial Chemotherapy in Clinical Practice ACCP |
|
| ( 119 pages ) |
|
| G. French | |
| Volume 16, Supplement 1: |
| Supplement Resistant Gram-positive Coccal Infections |
|
| ( 44 pages ) |
|
| M.R. Gismondo | |
| Volume 16, Number 4: |
| A selection of papers from a meeting on Resistance to Antimicrobial Agents (RAA) |
|
| ( 136 ) |
|
| J. Klastersky | |
| Volume 16, Number 2: |
| Proceedings of the 4th International Symposium on Febrile Neutropenia |
|
| ( 108 ) |
|
| J.-C. Gnanou, P. Sanders | |
| Volume 16, Number 1: |
| Antibiotic Resistance in Bacteria of Animal Origin |
|
| ( 82 ) |
|
| J.-G. Gnanou | |
| Volume 14, Number 4: |
| Antibiotic Resistance in Baceria from Animal Origin |
|
| ( 84 ) |
|
| F. Moosdeen, A.M. Sefton | |
| Volume 14, Number 3: |
| Non-antibiotic Compounds as Antimicrobial Agents |
|
| ( 100 ) |
|
| L.M. Baddour | |
| Volume 14, Number 2: |
| Gram-positive Cocci Infections in Humans |
|
| ( 78 ) |
|
| |
| Volume 14, Number 1: |
| Managing diarrhoea: A new approach to an old problem |
|
|
| J. Turnidge | |
| Vol. 12, no. 2: |
| Sodium Fusidate |
|
|
| F. Moosdeen | |
| Vol. 12, no. 1: |
| The role of sulbactam-ampicillin/sultamicillin in mixed infections |
|
|
| F. Moosdeen | |
| Vol. 12, no. 1: |
| The role of sulbactam-ampicillin/sultamicillin |
|
| ( 30 pages ) |
|
| J.D. Williams, H. Grimm | |
| Vol. 11, no. 1: |
| A Scientific Perspective on Macrolide Susceptibility |
|
|
| K.G. Naber, Y. Kawada | |
| Vol. 11, no. 3/4: |
| Urinary Tract Infection |
|
| ( 152 pages ) |
|
| H. Lode | |
| Vol. 6, Suppl.: |
| Microbiological and Clinical Activity of Sulbactam a Β–Lactamase Inhibitor |
|
| ( 90 pages ) |
|
| I.M. Hoepelman, M.G. Rinaldi | |
| Vol. 6, no. 3: |
| Epidemiology and Management of Systemic Fungal Infection |
|
| ( 58 pages ) |
|
| I.M. Hoepelman | |
| Vol. 5, no. 1: |
| Outpatient Treatment with Parenteral Antimicrobial Agents |
|
| ( 76 pages ) |
|
| V. Andriole, D. Lew | |
| Vol. 4, Suppl. 2: |
| Profile of Fleroxacin, a New Once Daily Quinolone |
|
| ( 64 pages ) |
|
| I.M. Hoepelman | |
| Vol. 4, no. 2: |
| Urinary Tract Infections |
|
| ( 62 pages ) |
|
| A.P.R. Wilson, R.N. Grüneberg, H. Neu | |
| Vol. 4, Suppl. 1: |
| A Critical Review of the Dosage of Teicoplanin in Europe and the USA |
|
| ( 34 pages ) |
|
| E. Bergogne–Bérézin | |
| Vol. 3, Suppl. 1: |
| Antibiotics and the Respiratory Tract |
|
| ( 130 pages ) |
|
| S.W.B. Newsom | |
| Vol. 2, no. 1: |
| Lomefloxacin: A Clinical Appraisal |
|
| ( iv + 80 pages ) |
|
| A. Williams | |
| Vol. 1, Suppl. 1: |
| Teicoplanin and the Physician |
|
| ( iv + 58 pages ) |
|
